ECO is a biopharmaceutical company that researches, develops and commercializes oncology products for the treatment of cancer... Read more
ECO is a biopharmaceutical company that researches, develops and commercializes oncology products for the treatment of cancer... Read more
Co-Founder & CEO
Xiaoming Zou
News
Aug 26, 2021
Contract Pharma
EOC Pharma: EOC Pharma and Chime Biologics Extend Partnership
Jan 22, 2021
Global Legal Chronicle
EOC Pharma: EOC Pharma's License and Collaboration Agreement for ABI-009
Jan 11, 2021
GlobalNewswire
Press Release: EOC Pharma : Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China
Jan 11, 2021
ChinaBio Today
EOC Pharma: EOC Signs $271 Million Agreement for mTor Inhibitor from Aadi Bio
Dec 10, 2020
Kalkine Media
EOC: Immutep, EOC Pharma launch Phase II trial on metastatic breast cancer patients in China
Dec 10, 2020
ChinaBio Today
EOC Pharma: EOC to Start China Trial of Novel Immunotherapy for Breast Cancer
Apr 08, 2020
MarketScreener
EOC: Immutep : Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer
Mar 22, 2020
Pharmabiz
EOC: EOC Pharma completes patient recruitment in phase I study of efti to treat metastatic breast cancer
Mar 20, 2020
MarketScreener
EOC: Immutep's Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti
Dec 04, 2019
Asian Venture Capital Journal
EOC: Local GPs commit $71m to China biotech player
